We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-2.02%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$618B
AUM Growth
-$16.6B
Cap. Flow
+$12.1B
Cap. Flow %
1.96%
Top 10 Hldgs %
19.92%
Holding
6,539
New
547
Increased
2,374
Reduced
2,724
Closed
514

Top Sells

Rank Stock Value
1
TRP icon
TC Energy
TRP
+$1.14B
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.13B
3
AVGO icon
Broadcom
AVGO
+$625M
4
UNH icon
UnitedHealth
UNH
+$584M
5
MA icon
Mastercard
MA
+$531M

Sector Composition

Rank Sector Weight
1 Technology 18.22%
2 Financials 9.75%
3 Consumer Discretionary 7.43%
4 Healthcare 7.41%
5 Industrials 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELEV
5876
DELISTED
Elevation Oncology
ELEV
$19.9K ﹤0.01%
76,646
-1,575,077
-95% -$899K
IGC icon
5877
IGC Pharma
IGC
$26.3M
$18.7K ﹤0.01%
65,541
INBS icon
5878
Intelligent Bio Solutions
INBS
$4.28M
$18.5K ﹤0.01%
+1,282
New +$23.9K
GROV icon
5879
Grove Collaborative
GROV
$46.7M
$18.4K ﹤0.01%
+13,624
New +$21.1K
BATL icon
5880
Battalion Oil
BATL
$28.6M
$17.7K ﹤0.01%
13,639
-176
-1% -$282
NFGC
5881
New Found Gold
NFGC
$591M
$17.4K ﹤0.01%
14,512
-57,559
-80% -$99.3K
PLBY icon
5882
Playboy Inc
PLBY
$134M
$17.1K ﹤0.01%
15,504
-74,620
-83% -$117K
ICU icon
5883
SeaStar Medical
ICU
$12.1M
$16.9K ﹤0.01%
1,020
-7
-0.7% -$132
CMLS
5884
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$16.7K ﹤0.01%
37,820
+6,132
+19% +$4.44K
VINC
5885
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$16.7K ﹤0.01%
31,567
-3
-0% -$5
BDMDW
5886
Baird Medical Investment Holdings Warrant
BDMDW
$543K
$16.5K ﹤0.01%
220,004
DRTSW icon
5887
Alpha Tau Medical Warrant
DRTSW
$78.9M
$16.5K ﹤0.01%
69,409
CLIR icon
5888
ClearSign Technologies
CLIR
$24.5M
$15.4K ﹤0.01%
2,049
-2,216
-52% -$22.1K
WBX
5889
Wallbox
WBX
$81M
$14.7K ﹤0.01%
2,245
-11,826
-84% -$108K
ORIO
5890
Orion Digital Corp
ORIO
$15.6M
$14.7K ﹤0.01%
17,099
+2,333
+16% +$2.65K
ZEOWW
5891
Zeo Energy Corp Warrants
ZEOWW
$103K
$14.2K ﹤0.01%
256,875
GGR icon
5892
Gogoro
GGR
$53.8M
$14K ﹤0.01%
2,586
-4,483
-63% -$37.8K
BDSX icon
5893
Biodesix
BDSX
$236M
$13.8K ﹤0.01%
1,105
-4,797
-81% -$92.1K
SBDS
5894
DELISTED
Solo Brands Inc
SBDS
$13.4K ﹤0.01%
1,997
-1,219
-38% -$37.4K
CUE icon
5895
Cue Biopharma
CUE
$112M
$13.1K ﹤0.01%
480
-671
-58% -$24.9K
GALT icon
5896
Galectin Therapeutics
GALT
$203M
$13.1K ﹤0.01%
10,699
-36,822
-77% -$51.7K
RDZNW icon
5897
Roadzen Inc Warrants
RDZNW
$6.9M
$12.7K ﹤0.01%
239,874
STI icon
5898
Solidion Technology
STI
$54.5M
$12.2K ﹤0.01%
2,021
-75
-4% -$1.3K
LDTCW
5899
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$12.1K ﹤0.01%
200,004
CREVW
5900
DELISTED
Carbon Revolution PLC Warrant
CREVW
$12.1K ﹤0.01%
309,716

Similar funds

Goldman Sachs's Q1 2025 Portfolio in Review

As of Q1 2025, Goldman Sachs held 6,539 positions worth $618B, down 2.6% from $634B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Goldman Sachs's Q1 2025 filing shows 547 new, 2,374 increased, 2,724 reduced and 514 closed positions. Its largest new stake was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M. The largest sale was TC Energy, an estimated $1.14B.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Goldman Sachs's largest Q1 2025 buy was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M.
  • Goldman Sachs added most to iShares Russell 2000 ETF in Q1 2025, an estimated $1.84B increase.
  • Goldman Sachs's biggest Q1 2025 reduction was TC Energy, cutting an estimated $1.14B.
  • Goldman Sachs fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $242M.
  • Goldman Sachs's ten largest holdings make up 20% of its $618B portfolio in Q1 2025.
  • Goldman Sachs opened 547 new positions and closed 514 in Q1 2025.
  • Goldman Sachs's portfolio value fell 2.6% quarter-over-quarter to $618B.

Based on Goldman Sachs's 13F filing for Q1 2025, filed 9 May 2025.